Shmuel Shoham

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Peter Donnelly, Sharon Chen, Carol A. Kauffman et al. · Clinical Infectious Diseases · 2019 · 2.6K citations · Full text

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)

Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker et al. · Clinical Infectious Diseases · 2020 · 1.1K citations · Full text

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 938 citations

Antifungal Agent, Isavuconazole Versus Voriconazole, Antifungal Agents +7

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

Samira M. Garonzik, Jian Li, Visanu Thamlikitkul et al. · Antimicrobial Agents and Chemotherapy · 2011 · 679 citations · Full text

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Sabra L. Klein, Andrew Pekosz, Han-Sol Park et al. · Journal of Clinical Investigation · 2020 · 472 citations · Full text